Plazza, a Bengaluru-based pharmacy-first quick commerce startup, has raised $15 million in a Series A funding round co-led by Accel, Elevation Capital, and Nexus Venture Partners. Existing investors All In Capital and Better Capital also participated in the round.
The fresh capital will go toward strengthening Plazza’s technology platform, deepening its AI-driven inventory and assortment intelligence, building out operational capabilities, and expanding its pharmacy network into new geographies.
The round arrives roughly 10 months after Plazza, founded in 2024 by Aman Priyadarshi, raised $1.4 million in a seed round led by All In Capital, with participation from Better Capital, Tracxn founder Abhishek Goyal, Vivekananda Hallekere, the Singhania family office, and promoters of JK Tyre. That quick jump from seed to a $15 million Series A signals investors are betting on pharmacy-focused quick commerce as a distinct, defensible category rather than a feature bolted onto general grocery delivery.
Plazza operates on a model built around deep inventory rather than speed alone. According to the company, each Plazza store stocks more than 40,000 SKUs — around eight times the range of a typical neighbourhood pharmacy — enabling prescription fill rates the company claims exceed 95%, compared with an industry average of 50% to 60%. The company also claims its gross merchandise value grew nearly 27X between June 2025 and March 2026, with repeat customers placing baskets roughly 30% larger than first-time users.
The bet is on a real gap in India’s pharmaceutical retail market: neighbourhood pharmacies typically carry around 5,000 medicines even though the broader market spans more than 100,000 SKUs, leaving frequent stockouts for anything beyond common prescriptions.
Plazza is entering a segment that has rapidly gone from a niche bet to a contested battleground. Flipkart entered quick medicine delivery through Flipkart Minutes in December 2024, while Zepto launched its own pharmacy vertical in 2025, promising 10-minute delivery in select cities. Blinkit has pushed beyond over-the-counter medicines by piloting prescription delivery in Bengaluru. Standalone online pharmacy players have also drawn capital of their own — PlatinumRx raised $6 million led by Stellaris Venture Partners in September 2025, while Truemeds secured $85 million in a round led by Accel and Peak XV Partners.
With three of India’s most active early-stage investors now backing Plazza directly, the startup’s near-term challenge shifts from proving demand to defending margins as horizontal quick commerce platforms encroach on pharmacy as just another delivery category rather than a specialised one.
